Cambridge biotech Sarepta wins fast-track approval for the first muscular dystrophy gene therapy
The FDA limited the approval of Sarepta Therapeutics’ treatment to patients ages 4 to 5 years old who still have the ability to walk.
Stay updated with breaking news from Ruby Wallau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA limited the approval of Sarepta Therapeutics’ treatment to patients ages 4 to 5 years old who still have the ability to walk.
The prospect of “accelerated approval” for a single-dose treatment for Duchenne muscular dystrophy has drawn criticism from some scientists and health research experts who say the FDA is loosening its standards.
Bay Area native Edin Haddis surprises family as the student speaker at Mills College at Northeastern commencement.
Mills College at Northeastern celebrates its first commencement ceremony and listens to Michèle Taylor's inspiring story.
10 things to do in Boston this weekend, April 27-30, 2023, including the Massachusetts Craft Brewers Festival, Impractical Jokers, and more.